» Articles » PMID: 28941101

Schizophrenia and the Neurodevelopmental Continuum:evidence from Genomics

Overview
Specialty Psychiatry
Date 2017 Sep 24
PMID 28941101
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

The idea that disturbances occurring early in brain development contribute to the pathogenesis of schizophrenia, often referred to as the neurodevelopmental hypothesis, has become widely accepted. Despite this, the disorder is viewed as being distinct nosologically, and by implication pathophysiologically and clinically, from syndromes such as autism spectrum disorders, attention-deficit/hyperactivity disorder (ADHD) and intellectual disability, which typically present in childhood and are grouped together as "neurodevelopmental disorders". An alternative view is that neurodevelopmental disorders, including schizophrenia, rather than being etiologically discrete entities, are better conceptualized as lying on an etiological and neurodevelopmental continuum, with the major clinical syndromes reflecting the severity, timing and predominant pattern of abnormal brain development and resulting functional abnormalities. It has also been suggested that, within the neurodevelopmental continuum, severe mental illnesses occupy a gradient of decreasing neurodevelopmental impairment as follows: intellectual disability, autism spectrum disorders, ADHD, schizophrenia and bipolar disorder. Recent genomic studies have identified large numbers of specific risk DNA changes and offer a direct and robust test of the predictions of the neurodevelopmental continuum model and gradient hypothesis. These findings are reviewed in detail. They not only support the view that schizophrenia is a disorder whose origins lie in disturbances of brain development, but also that it shares genetic risk and pathogenic mechanisms with the early onset neurodevelopmental disorders (intellectual disability, autism spectrum disorders and ADHD). They also support the idea that these disorders lie on a gradient of severity, implying that they differ to some extent quantitatively as well as qualitatively. These findings have important implications for nosology, clinical practice and research.

Citing Articles

Potentially causal associations between placental DNA methylation and schizophrenia and other neuropsychiatric disorders.

Cilleros-Portet A, Lesseur C, Mari S, Cosin-Tomas M, Lozano M, Irizar A Nat Commun. 2025; 16(1):2431.

PMID: 40087310 DOI: 10.1038/s41467-025-57760-3.


Autism spectrum disorder, social anxiety and obsessive-compulsive disorders: beyond the comorbidity.

DellOsso L, Amatori G, Bonelli C, Nardi B, Massimetti E, Cremone I BMC Psychiatry. 2025; 25(1):37.

PMID: 39806378 PMC: 11727392. DOI: 10.1186/s12888-024-06340-8.


Genetic analysis of psychosis Biotypes: shared Ancestry-adjusted polygenic risk and unique genomic associations.

Xia C, Alliey-Rodriguez N, Tamminga C, Keshavan M, Pearlson G, Keedy S Mol Psychiatry. 2024; .

PMID: 39709506 DOI: 10.1038/s41380-024-02876-z.


Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic Associations.

Xia C, Alliey-Rodriguez N, Tamminga C, Keshavan M, Pearlson G, Keedy S medRxiv. 2024; .

PMID: 39677452 PMC: 11643284. DOI: 10.1101/2024.12.05.24318404.


Exploring the longitudinal course of motor dexterity in first-episode psychosis: a 10-year follow-up.

Sevilla-Ramos M, Ladera V, Garcia-Garcia R, Crespo-Facorro B, Ayesa-Arriola R Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 39503784 DOI: 10.1007/s00406-024-01937-2.


References
1.
Kataoka M, Matoba N, Sawada T, Kazuno A, Ishiwata M, Fujii K . Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations. Mol Psychiatry. 2016; 21(7):885-93. PMC: 5414074. DOI: 10.1038/mp.2016.69. View

2.
Sullivan P, Daly M, ODonovan M . Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet. 2012; 13(8):537-51. PMC: 4110909. DOI: 10.1038/nrg3240. View

3.
Malhotra D, Sebat J . CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012; 148(6):1223-41. PMC: 3351385. DOI: 10.1016/j.cell.2012.02.039. View

4.
Sullivan P, Magnusson C, Reichenberg A, Boman M, Dalman C, Davidson M . Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry. 2012; 69(11):1099-1103. PMC: 4187103. DOI: 10.1001/archgenpsychiatry.2012.730. View

5.
. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017; 542(7642):433-438. PMC: 6016744. DOI: 10.1038/nature21062. View